- Home
- IMNM vs HBANP Comparison
IMNM vs HBANP Comparison
Compare IMNM & HBANP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- HBANP
- Stock Information
- Founded
- IMNM 2006
- HBANP N/A
- Country
- IMNM United States
- HBANP United States
- Employees
- IMNM N/A
- HBANP 20043
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- HBANP Major Banks
- Sector
- IMNM Health Care
- HBANP Finance
- Exchange
- IMNM Nasdaq
- HBANP Nasdaq
- Market Cap
- IMNM 747.7M
- HBANP N/A
- IPO Year
- IMNM 2020
- HBANP N/A
- Fundamental
- Price
- IMNM $10.97
- HBANP $17.88
- Analyst Decision
- IMNM Strong Buy
- HBANP
- Analyst Count
- IMNM 5
- HBANP 0
- Target Price
- IMNM $28.60
- HBANP N/A
- AVG Volume (30 Days)
- IMNM 911.8K
- HBANP N/A
- Earning Date
- IMNM 11-13-2024
- HBANP N/A
- Dividend Yield
- IMNM N/A
- HBANP N/A
- EPS Growth
- IMNM N/A
- HBANP N/A
- EPS
- IMNM N/A
- HBANP N/A
- Revenue
- IMNM $10,129,000.00
- HBANP N/A
- Revenue This Year
- IMNM N/A
- HBANP N/A
- Revenue Next Year
- IMNM N/A
- HBANP N/A
- P/E Ratio
- IMNM N/A
- HBANP N/A
- Revenue Growth
- IMNM N/A
- HBANP N/A
- 52 Week Low
- IMNM $8.33
- HBANP N/A
- 52 Week High
- IMNM $30.96
- HBANP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 39.61
- HBANP 30.58
- Support Level
- IMNM $10.76
- HBANP $17.44
- Resistance Level
- IMNM $15.13
- HBANP $19.21
- Average True Range (ATR)
- IMNM 0.98
- HBANP 0.33
- MACD
- IMNM -0.29
- HBANP -0.11
- Stochastic Oscillator
- IMNM 4.81
- HBANP 22.76
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About HBANP Huntington Bancshares
Huntington is a regional us bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.